Axonics Modulation Technologies, Inc. (AXNX) News

Axonics Modulation Technologies, Inc. (AXNX): $71.07

0.07 (+0.10%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Filter AXNX News Items

AXNX News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

AXNX News Highlights

  • 500 - Internal server error
  • Over the past 6 days, the trend for AXNX's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
  • The most mentioned tickers in articles about AXNX are INS and CE.

Latest AXNX News From Around the Web

Below are the latest news stories about Axonics Inc that investors may wish to consider to help them evaluate AXNX as an investment opportunity.

Axonics' implantable sacral neurostimulator gets European CE mark

Axonics (AXNX) announces European CE Mark approval of its second generation Axonics r-SNM implantable neurostimulator ((INS)) and wireless patient remote control with SmartMRI technology. Axonics previously received FDA approval for this INS and remote control during 2020. This version reduces how frequently a patient needs to recharge their sacral neuromodulation device...

Seeking Alpha | May 18, 2021

Axonics secures $175M capital via equity raise

Axonics (AXNX) has priced its public offering of 3.5M common shares at $50.00/share, for expected gross proceeds of $175M.Underwriters' over-allotment is an additional 525K shares. Net proceeds will be used to repay outstanding indebtedness, for commercialization purpose, R&D activities, working capital and general corporate purposes.Closing date is May 14.Shares down 4.6% after-hours.Previously...

Seeking Alpha | May 12, 2021


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4211 seconds.